Works matching IS 02780232 AND DT 2024 AND VI 42 AND IP 4

Results: 14

Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3292

By:

Ishitsuka, Kenji;
Yasukawa, Tomoharu;
Tsuji, Yukie

Publication type:

Article

Strategies for overcoming resistance to Bruton's tyrosine kinase inhibitor zanubrutinib.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3294

By:

Dostálová, Hana;
Kryštof, Vladimír

Publication type:

Article

Clonal dynamics of Richter transformation in chronic lymphocytic leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3282

By:

Wang, Hanyin;
Tian, Shulan;
Secreto, Charla R.;
Sinha, Sutapa;
Shi, Min;
Call, Timothy;
Wang, Yucai;
Parikh, Sameer A.;
Kenderian, Saad S.;
He, Rong;
Leis, Jose F.;
VanDyke, Daniel L.;
Klee, Eric W.;
Slager, Susan L.;
Braggio, Esteban;
Yan, Huihuang;
Ding, Wei

Publication type:

Article

Evaluation of participation and recruitment bias in a prospective Real World Data in Lymphoma and Survival in Adults (REALYSA) cohort for newly diagnosed lymphoma patients over 1 year in a hematology department of teaching hospital.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3297

By:

Lan, Caroline Le;
Belot, Aurélien;
Golfier, Camille;
Audin, Bérénice;
Sesques, Pierre;
Bernier, Adeline;
Safar, Violaine;
Ferrant, Emmanuelle;
Lazareth, Anne;
Lequeu, Hélène;
Karlin, Lionel;
Ghergus, Dana;
Maarek, Alizée;
Aussedat, Guillaume;
Idlhaj, Maryam;
Salles, Gilles;
Cherblanc, Fanny;
Bachy, Emmanuel;
Ghesquieres, Hervé

Publication type:

Article

Venetoclax combined with daunorubicin and cytarabine (2 + 6) in acute myeloid leukemia: Updated results of a phase II trial.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3296

By:

Suo, Xiaohui;
Fang, Zheng;
Wang, Dongmei;
Zhao, Liyun;
Liu, Jie;
Li, Hong;
Ma, Xiaojun;
Zhang, Congcong;
Zhao, Xuemei;
Shi, Rui;
Wu, Yan;
Jiao, Zongjiu;
Song, Jiaojie;
Zhang, Ling;
Li, Ling;
Zhang, Suping;
Lu, Xinxiao;
Yuan, Linyu;
Gao, Sifeng;
Zhang, Jilei

Publication type:

Article

Prescription patterns of venetoclax in acute myeloid leukemia.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3298

By:

Ucciero, Andrealuna;
Traversa, Giuseppe;
Pisterna, Alessia;
Cardinali, Valeria;
Sciabolacci, Sofia;
Poloni, Antonella;
Capelli, Debora;
Gaidano, Gianluca;
Patriarca, Andrea;
Lunghi, Monia

Publication type:

Article

Outcomes of therapeutic plasma exchange for the treatment of patients with multiple myeloma cast nephropathy.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3293

By:

Dima, Danai;
Goel, Utkarsh;
Sannareddy, Aishwarya;
Ibeh, Nnaemeka;
Ullah, Fauzia;
Afrough, Aimaz;
Mazzoni, Sandra;
Mehdi, Ali;
Rudoni, Joslyn;
Raza, Shahzad;
De Simone, Nicole;
Williams, Louis;
Khan, Adeel;
Rashid, Aliya;
Rice, Mikhaila;
Ricci, Kristin;
Samaras, Christy;
Valent, Jason;
Anderson, Larry D.;
Anwer, Faiz

Publication type:

Article

TET2 regulates extranodal NK/T cell lymphoma progression through regulation of DNA methylation.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3295

By:

Xiang, Chunxiang;
Gao, Limin;
Tao, Qing;
Chen, Zihang;
Zhao, Sha;
Liu, Weiping

Publication type:

Article

Metabolic pathway‐based subtyping reveals distinct microenvironmental states associated with diffuse large B‐cell lymphoma outcomes.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3279

By:

Wang, Xiaohui;
Liu, Hengqi;
Fei, Yue;
Song, Zheng;
Meng, Xiangrui;
Yu, Jingwei;
Liu, Xia;
Li, Lanfang;
Qiu, Lihua;
Qian, Zhengzi;
Zhou, Shiyong;
Wang, Xianhuo;
Zhang, Huilai

Publication type:

Article

Correction to Staging FDG‐avidity in extranodal marginal zone lymphoma (EMZL) by disease location.

Published in:: 2024
Publication type:: Correction Notice

Issue Information.

Published in:: Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3180
Publication type:: Article

Correction to Real‐life study on the use of response adapted therapy in patients with Hodgkin Lymphoma: Results from a multicenter experience.

Published in:: 2024
Publication type:: Correction Notice

Elotuzumab plus pomalidomide and dexamethasone in relapsed/refractory multiple myeloma: Extended follow‐up of a multicenter, retrospective real‐world experience with 321 cases outside of controlled clinical trials.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3290

By:

Martino, Enrica Antonia;
Palmieri, Salvatore;
Galli, Monica;
Derudas, Daniele;
Mina, Roberto;
Della Pepa, Roberta;
Zambello, Renato;
Vigna, Ernesto;
Bruzzese, Antonella;
Mangiacavalli, Silvia;
Zamagni, Elena;
Califano, Catello;
Musso, Maurizio;
Conticello, Concetta;
Cerchione, Claudio;
Mele, Giuseppe;
Di Renzo, Nicola;
Offidani, Massimo;
Tarantini, Giuseppe;
Casaluci, Gloria Margiotta

Publication type:

Article

A real‐life study of daratumumab combinations in newly diagnosed patients with light chain (AL) amyloidosis.

Published in:

Hematological Oncology, 2024, v. 42, n. 4, p. 1, doi. 10.1002/hon.3289

By:

Bellofiore, Claudia;
Benvenuti, Pietro;
Mina, Roberto;
Basset, Marco;
Foli, Andrea;
Nanci, Martina;
Nuvolone, Mario;
Guida, Gianluigi;
Attanasio, Andrea;
Mussinelli, Roberta;
Mangiacavalli, Silvia;
Cartia, Claudio Salvatore;
Masoni, Valeria;
Palumbo, Michele;
Cani, Lorenzo;
Oliva, Stefania;
Consoli, Ugo;
Conticello, Concetta;
Di Raimondo, Francesco;
Arcaini, Luca

Publication type:

Article